Conclusion: This review found strong evidence for A. paniculata and ivy/primrose/thyme-based preparations and moderate evidence for P. sidoides being significantly superior to placebo in alleviating the frequency and severity of patients' cough symptoms. Additional research, including other herbal treatments, is needed in this area.
PubMed 26840418 ↗Andrographis
The short answer. There isn't much data on Andrographis yet — 38 mentions, 11 with a clear outcome — so treat these numbers as anecdotal. It is well studied — 18 meta-analyses on PubMed.
From 38 mentions in total — the rest didn't say how it went and aren't counted.
What Andrographis does, according to users
Of the people who reported each effect, the share who said it got better.
6 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 18 meta-analyses on PubMed ↗ · 24 randomized trials ↗
Conclusion: Like other medicine, Andrographis paniculata can cause some AEs. However, it may be generally safe. Nevertheless, prospective patients who plan to use Andrographis paniculata should be thoroughly advised and closely monitored for common AEs. Due to the increasing use of Andrographis paniculata worldwide, larger studies with adequate methodological quality are warranted to monitor the safety of such product.
PubMed 33372366 ↗Conclusion: Complementary and alternative therapies might be effective for the treatment of inflammatory bowel diseases; however, given the low number of trials and the heterogeneous methodological quality of trials, further in-depth research is necessary.
PubMed 25518050 ↗Conclusion: These findings highlight the need for further research to explore AP as a complementary therapeutic strategy in COVID-19 management. https://www.crd.york.ac.uk/PROSPERO/view/CRD42024608858, identifier CRD42024608858.
PubMed 40822451 ↗26 human trials on ClinicalTrials.gov test Andrographis — 13 completed. See all on ClinicalTrials.gov ↗
- To Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suffering From Osteoarthritis of Knee Joint. · Knee Osteoarthritis (Knee OA) · 2024
- Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery · COVID 19 · 2022
- To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI · Upper Respiratory Tract Infection · 2022
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
1 recall of products named for Andrographis. Most recent:
- 2016-05-04 · Class II: Undeclared soy lecithin in 5 dietary supplements. record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
The EMA reviewed Kalmegh and did not issue a monograph (public statement). EMA ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“This works really well as a daily anti-inflammatory for me, which seems to help quite a bit.”
“It lower inflammation, histamine and glutamate, modulate immune. It makes me calm similar to 250mg agmatine.”
“Have you tried Andrographis? For me it has been a very interesting one since it's helped me be a little more chill and my sleep has been amazing”
“I have noticed Andrographis has helped. I've been taking it before bed with low dose melatonin”
Other options for pain & inflammation
Sources
- User reports: 38 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA recalls ↗
- European Medicines Agency ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate